Table 2.

Illicit opioid drug use at delivery

OPIOID USEWOMEN EXPOSED TO BUPRENORPHINE-NALOXONE (N = 30), N (%)WOMEN EXPOSED TO OTHER OPIOIDS (N = 134), N (%)
Quit*24 (80.0)49 (36.6)
Decreased3 (10.0)53 (39.6)
Increased0 (0.0)1 (0.7)
No change1 (3.3)23 (17.2)
Unknown2 (6.7)8 (6.0)
  • * Significantly more women in the group exposed to buprenorphinenaloxone had quit using illicit opioids at delivery (P < .001).